Objective: To analyze the medication characteristics and regularities of proprietary Chinese medicines for the treatment of insomnia, and to provide new ideas for the clinical treatment of this disease and the research and development of proprietary Chinese medicines. Methods: The prescriptions of proprietary Chinese medicines for the treatment of insomnia were collected from“yaoZH” database, and then Excel 2016, and SPSS Modeler18.0 was employed for frequency statistics, correlation analysis and Apriori association rule. Analysis graphs were drawn using Cytoscape to summarize the patterns of medication use Results: A total of 152 prescriptions were finally screened, involving 336 Chinese herbal medicines, with a cumulative frequency of 1433. The top 5 drugs with the highest cumulative frequency were Danggui (3.07%), Fuling (2.86%), Wuweizi (2.86%), Shudihuang (2.58%) and Huangqi (2.37%). The first place of each order of the drug-drug association rule was Danggui→ Zhiyuanzhi, Chaosuanzaoren+ Danggui→ Fuling; the first place of each order of the drug-symptom association rule was Fuling → Insomnia, Fuling + Danggui → Insomnia. In addition, 152 Chinese patent medicines could treat a total of 66 TCM syndromes, and the top 5 syndromes with the highest treatment frequency were Qi and Blood Deficiency Syndrome (16.5%), Liver and Kidney Deficiency Syndrome (10.9%), Heart and Spleen Deficiency Syndrome (5.21%), Qi and Yin Deficiency Syndrome (4.73%), and Liver Yang Hyperactivity Syndrome (4.26%). Conclusion: The treatment of insomnia with proprietary Chinese medicines is focused on nourishing deficiency, and is particularly good at treating insomnia caused by deficiency of Qi and Blood, deficiency of Liver and Kidney or deficiency of Heart and Spleen, and its main treatment symptoms, apart from insomnia, are most often accompanied by palpitations, fatigue, dizziness and memory loss, which can provide a basis for the clinical treatment of insomnia and the development of proprietary Chinese medicines.

Yingliang Zhou, Ying Wang, Sijia Zhang, Ru Wang, Jie Chen. Analysis of the Prescription Regularities of Proprietary Chinese Medicines for Insomnia Based on Data mining. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 4: 28-35. https://doi.org/10.25236/IJFM.2023.050406.

[1] Chinese Sleep Research Society. Chinese guidelines for the diagnosis and treatment of insomnia [J]. Chin J Med, 2017,97(24):1844-1856. 

[2] Su L, LU Z. Interpretation of 2017 Chinese guidelines for the diagnosis and treatment of insomnia [J]. World Clinical Medicine,2018,39(04):217-222. 

[3] Bragg S, Benich JJ, Christian N, et al.  Updates in insomnia diagnosis and treatment[J]. Int J Psychiatry Med. 2019;54(4-5):275-289.

[4] Jia Yu, Jia Yuejin, Zheng Xiaolin. Chinese Journal of Traditional Chinese Medicine, 2015, 30(01): 163-166. (in Chinese with English abstract)

[5] Wang Hua, Sun Na. Research progress on effective chemical components and pharmacological effects of Danggui [J]. Shandong Chemical Industry, 2017,46(18):59-60.

[6] Zhu Yun, Zhong Yu, Liu Xiaoli, et al. Study on the mechanism of Danggui volatile oil in the treatment of insomnia based on network pharmacology [J]. Chinese Patent Materia Medica, 2012, 44(03): 1000-1005.

[7] State Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China: Part I [M]. Beijing: China Medical Science and Technology Press, 2020. (in Chinese) 

[8] Kim H, Park I, Park K, et al.  The Positive Effects of Poria cocos Extract on Quality of Sleep in Insomnia Rat Models[J]. Int J Environ Res Public Health.2022;19(11):6629. 

[9] Cui H R, Wang R L, Guo W B, et al. Research progress on chemical composition, pharmacological action and clinical application of Fuling [J]. Northwest Pharmaceutical Journal,2019,34(05):694-700. 

[10] Zhang F, Zhai J, Weng N, Gao J, et al. A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities[J]. Front Pharmacol. 2022;13:816036.

[11] Zhang Yuchong, Wang Mengyang, Lin Huijiao, et al. Effects of Wuweizi lignan on insomnia in rats induced by chlorphenylalanine [J]. Chin J Gerontology,2020,40(04):861-863.

[12] Zhang Y, Huang J S, WU S Y, et al. Clinical characteristics analysis of 1379 cases of primary insomnia in traditional Chinese medicine symptoms and syndrome types [J]. Chin J Traditional Chinese Medicine, 2017, 32(04):1704-1707. 

[13] Zhang M, Huang J S, ZHANG Y, et al. Study on the distribution of TCM syndromes in 1447 patients with insomnia [J]. Chin J Traditional Chinese Medicine,2017,32(04):1778-1781. 

[14] Ma K, Liu F, Shou YK, et al.  Analysis on academic characteristics and medication rules of traditional Chinese medical master Liu Zu-yi for treating insomnia[J]. Zhongguo Zhong Yao Za Zhi. 2019; 44(12):2607-2615. 

[15] Chung K F , Yeung W F , Yu Y M , et al. A population-based 2-year longitudinal study of insomnia disorder in a Chinese population in Hong Kong [J]. Psychology, Health & Medicine, 2017, 23(5):1-6. 

[16] Lin L, Chen J, Wang Y, et al. Retrospective study on Buzhongyiqi decoction and Wuling Powder in the treatment of insomnia with qi deficiency and water stagnation [J]. Hebei Traditional Chinese Medicine, 2021, 43(06):907-912.

[17] Huang Xueying, Zhang Wei. A case report of insomnia of cold water stopping with Wuling-Sanqu Gui-Jia-Shao decoction and Longli Li [J]. World J Sleep Med,2021,8(02):362-363.

[18] Gong Ming, Zhang Wei. A case report of Xuefu Zhuyu decoction and Wuling Powder in the treatment of insomnia [J]. World Journal of Sleep Medicine,2019,6(02):173-174.

[19] XU Feifei, TIAN Yajuan, LI Qinqing, et al. Study on the effect and mechanism of water extract of Ziziphus jujube and fuling-Codonopsis ginseng on the sleep of mice [J]. Science and Technology of Food Industry, 2021, 42(11):300-308.

[20] Zhu Xiaochai, LIU Xiao, WANG Xiaoli, et al. Historical evolution of Processing Methods and material basis of sedative and hypnotic effect of jujube kernel based on the theory of "effective ripening and increasing" [J]. Chinese Materia Medica, 2017, 40(08):1991-1995. 

[21] Yang F, Yu H, Chai X, et al. Illumination on "Reserving Phloem and Discarding Xylem" and Quality Evaluation of Radix polygalae by Determining Oligosaccharide Esters, Saponins, and Xanthones [J]. Molecules. 2018; 23(4):836. 

[22] Ren XJ, Wang GY, Zhang XP, et al. Sedative and Hypnotic Effects and Transcriptome Analysis of Polygala tenuifolia in Aged Insomnia Rats[J]. Chin J Integr Med. 2020; 26(6):434-441. 

[23] Xie Guangjing, Huang Panpan, Wang Ping. Effect of Tianwangbuxin Dan on oxidative damage of Trx system in PCPA rats with insomnia [J]. Chinese Journal of Experimental Formulary, 2019, 25(06): 32-38.

[24] Guo Haibo, Wang Hui. Research progress and discussion on the modern mechanism of Zizaoren decoction in the treatment of insomnia [J]. Chin J Traditional Chinese Medicine, 2019, 37(12): 2963-2966.

[25] Tong Xiaolin, He Lisha, Zhao Linhua. On the clinical differentiation and treatment strategy of "state target cause and effect" in traditional Chinese medicine [J]. Chinese Journal of Traditional Chinese Medicine, 2015, 56(17):1441-1444.

[26] Gao H. Diagnostic criteria for chronic insomnia disorder in the International Classification of Sleep Disorders (3rd edition) [J]. World Journal of Sleep Medicine,2018,5(05):555-557.

[27] Li Xueli, Zhang Bin. Association between sleep disorders and anxiety and depression disorders [J]. Chinese Journal of Clinicians, 2018, 46(02):131-133.